Poorly cohesive gastric carcinoma
Poorly Cohesive Gastric Carcinoma (PCGC), also known as signet ring cell carcinoma when the majority of the tumor cells have a signet ring cell appearance, is a distinct type of gastric cancer characterized by poorly cohesive cells, including cells that may appear isolated or in small clusters without forming glandular structures. This form of cancer is aggressive and often diagnosed at an advanced stage. Understanding its pathology, epidemiology, and treatment options is crucial for managing this disease.
Epidemiology[edit]
PCGC is more common in younger patients and has a slightly higher prevalence in females compared to other types of gastric cancer. The incidence of PCGC has been increasing globally, contrasting with the declining rates of other forms of gastric cancer. This trend suggests distinct etiological factors or lifestyle changes affecting its prevalence.
Pathophysiology[edit]
The hallmark of PCGC is the presence of poorly cohesive cells, often with signet ring cell features. These cells are characterized by the presence of a large vacuole displacing the nucleus to the periphery, giving the cell a signet ring appearance. The lack of cohesion among tumor cells is thought to be due to reduced expression of E-cadherin, a cell adhesion molecule, leading to an aggressive behavior with a propensity for diffuse infiltration of the stomach wall and early metastasis.
Clinical Presentation[edit]
Patients with PCGC may present with non-specific symptoms such as weight loss, abdominal pain, or nausea. Due to its aggressive nature, PCGC often presents at an advanced stage with signs of gastric outlet obstruction, peritoneal dissemination, or metastasis to distant organs including the liver and lungs.
Diagnosis[edit]
Diagnosis of PCGC involves a combination of endoscopic examination and histopathological analysis of biopsy specimens. Endoscopy may reveal thickening of the stomach wall or a linitis plastica appearance without a well-defined mass. Histopathology confirms the diagnosis by demonstrating poorly cohesive cells, often with signet ring cell features.
Treatment[edit]
The treatment of PCGC typically involves a multimodal approach. Surgical resection remains the cornerstone of curative treatment, often requiring total gastrectomy due to the diffuse nature of the disease. Chemotherapy and, in some cases, radiation therapy may be used as neoadjuvant or adjuvant treatments to improve survival rates. However, the prognosis of PCGC remains poor, with a high rate of recurrence and metastasis.
Prognosis[edit]
The prognosis of PCGC is generally poor compared to other types of gastric cancer, mainly due to its aggressive behavior and tendency for early dissemination. The overall survival rate is significantly lower, highlighting the need for early detection and aggressive treatment strategies.
Conclusion[edit]
Poorly Cohesive Gastric Carcinoma represents a challenging form of gastric cancer with distinct clinical and pathological features. Its aggressive nature and poor prognosis necessitate ongoing research into more effective diagnostic and therapeutic strategies. Early detection and a multidisciplinary approach to treatment are crucial in managing this disease.
Ad. Transform your life with W8MD's Budget GLP-1 injections from $49.99


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $49.99 for the starting dose of Semaglutide and $65.00 for Tirzepatide.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
Linkedin_Shiny_Icon Facebook_Shiny_Icon YouTube_icon_(2011-2013) Google plus
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian